Milestone Pharmaceuticals (MIST) Total Liabilities (2018 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Total Liabilities came in at $157.7 million in Q1 2026, up 131.86% YoY from $68.0 million in Q1 2025, and up 119.64% on a QoQ basis from $71.8 million in Q4 2025.
Milestone Pharmaceuticals (MIST) Total Liabilities (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 9 years of Total Liabilities data on file, last reported at $157.7 million in Q1 2026.
- Quarterly Total Liabilities rose 131.86% year-over-year to $157.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $157.7 million (up 131.86% YoY) and the FY2025 annual result came in at $71.8 million, up 15.14% from the prior year.
- Total Liabilities advanced to $157.7 million in Q1 2026, from $71.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $157.7 million in Q1 2026 to a low of $4.6 million in Q2 2022.
- A 5-year average of $54.2 million and a median of $58.5 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities decreased 21.83% — and 2023, when it jumped 1120.06%.
- Tracing MIST's Total Liabilities over 5 years: stood at $8.1 million in 2022, then jumped by 618.56% to $58.5 million in 2023, then advanced by 6.67% to $62.4 million in 2024, then grew by 15.14% to $71.8 million in 2025, then soared by 119.64% to $157.7 million in 2026.
- The last three Total Liabilities figures came in at $157.7 million (Q1 2026), $71.8 million (Q4 2025), and $67.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - | 163.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 163.41 Mn |
| Mar 31, 2026 | 157.69 Mn |
| Dec 31, 2025 | 71.79 Mn |
| Sep 30, 2025 | 67.25 Mn |
| Jun 30, 2025 | 65.16 Mn |
| Mar 31, 2025 | 68.01 Mn |
| Dec 31, 2024 | 62.35 Mn |
| Sep 30, 2024 | 58.69 Mn |
| Jun 30, 2024 | 57.25 Mn |
| Mar 31, 2024 | 56.08 Mn |
| Dec 31, 2023 | 58.46 Mn |
| Sep 30, 2023 | 58.61 Mn |
| Jun 30, 2023 | 56.61 Mn |
| Mar 31, 2023 | 57.15 Mn |
| Dec 31, 2022 | 8.14 Mn |
| Sep 30, 2022 | 8.61 Mn |
| Jun 30, 2022 | 4.64 Mn |
| Mar 31, 2022 | 5.04 Mn |
| Dec 31, 2021 | 7.25 Mn |
| Sep 30, 2021 | 6.36 Mn |